HBV-MPL vaccine

BIOLOGICAL4 trials

Sponsors

GlaxoSmithKline

Conditions

Hepatitis B

Phase 2

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

CompletedNCT00697229

GlaxoSmithKlineHepatitis B

Start: 1992-09-30End: 1998-12-31Updated: 2008-06-13

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y

CompletedNCT00698555

GlaxoSmithKlineHepatitis B

Start: 1997-03-31Updated: 2008-06-17

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y

CompletedNCT00698906

GlaxoSmithKlineHepatitis B

Start: 1997-06-30Updated: 2008-06-17

Phase 3

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

CompletedNCT00696891

GlaxoSmithKlineHepatitis B

Start: 1997-06-30Updated: 2008-06-13